ask="1.54"
ask_size="500"
average_daily_volume="380090"
bid="1.31"
bid_size="700"
book_value="0.12"
change="-0.33"
change_from_200_day_moving_average="0.22"
change_from_50_day_moving_average="0.39"
change_from_52_week_high="-1.58"
change_From_52_week_low="0.98"
change_in_percent="-18.33%"
close="1.47"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.83"
ebitda="-21.56M"
eps_estimate_current_year="-0.81"
eps_estimate_next_quarter="-0.18"
eps_estimate_next_year="-0.87"
ex_dividend_date="N/A"
float_shares="18812000"
high="1.78"
high_52_weeks="3.05"
last_trade_date="2/15/2017"
last_trade_price="1.47"
last_trade_size="1396"
last_trade_time="4:00pm"
low="1.40"
low_52_weeks="0.49"
market_capitalization="43.21M"
moving_average_200_day="1.25"
moving_average_50_day="1.08"
name="Galectin Therapeutics Inc."
notes="N/A"
one_year_target_price="1.12"
open="1.66"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+17.20%"
percent_change_from_50_day_moving_average="+35.58%"
percent_change_from_52_week_high="-51.80%"
percent_change_from_52_week_low="+200.00%"
previous_close="1.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="14.40"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="29396000"
short_ratio="3.96"
stock_exchange="NCM"
symbol="GALT"
volume="1319699"
weeks_range_52="0.49 - 3.05"
